Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 Aug;27(8):1748–1753. doi: 10.1128/jcm.27.8.1748-1753.1989

Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis.

S Carozzi 1, M Salit 1, A Cantaluppi 1, M G Nasini 1, S Barocci 1, S Cantarella 1, S Lamperi 1
PMCID: PMC267666  PMID: 2504774

Abstract

We analyzed the effects of monophosphoryl lipid A (MPL), a relatively nontoxic immunostimulant derived from bacterial endotoxin, on the depressed in vitro immune function of leukocytes derived from six patients undergoing continuous ambulatory peritoneal dialysis and who had histories of recurrent bacterial peritonitis. MPL was also tested for its capacity to stimulate the proliferation of peritoneal fibroblasts, as determined by [3H]thymidine incorporation. In vitro incubation of peritoneal lymphocytes and macrophages (PM phi) with increasing amounts of MPL, up to 5 micrograms/ml, resulted in a dose-dependent enhancement of gamma interferon and interleukin-2 production by peritoneal lymphocytes and interleukin-1 release by PM phi. In vitro incubation of PM phi with MPL also resulted in an increase of PM phi bacterial killing and membrane Fc receptor number, although no change in peritoneal fibroblast proliferation was seen with any of the MPL concentrations tested. These results suggest that the peritoneal leukocyte dysfunction observed in patients undergoing continuous ambulatory peritoneal dialysis and who have high rates of peritonitis may be alleviated, to some degree, by MPL, without directly inducing a potentially deleterious fibrotic lesion.

Full text

PDF
1748

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinckerhoff C. E., Guyre P. M. Increased proliferation of human synovial fibroblasts treated with recombinant immune interferon. J Immunol. 1985 May;134(5):3142–3146. [PubMed] [Google Scholar]
  2. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  3. Dayer J. M., Krane S. M., Russell R. G., Robinson D. R. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A. 1976 Mar;73(3):945–949. doi: 10.1073/pnas.73.3.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dukovich M., Severin J. M., White S. J., Yamazaki S., Mizel S. B. Stimulation of fibroblast proliferation and prostaglandin production by purified recombinant murine interleukin 1. Clin Immunol Immunopathol. 1986 Mar;38(3):381–389. doi: 10.1016/0090-1229(86)90248-5. [DOI] [PubMed] [Google Scholar]
  5. Gery I., Davies P., Derr J., Krett N., Barranger J. A. Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents. Cell Immunol. 1981 Nov 1;64(2):293–303. doi: 10.1016/0008-8749(81)90481-0. [DOI] [PubMed] [Google Scholar]
  6. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  7. Goding J. W. Conjugation of antibodies with fluorochromes: modifications to the standard methods. J Immunol Methods. 1976;13(3-4):215–226. doi: 10.1016/0022-1759(76)90068-5. [DOI] [PubMed] [Google Scholar]
  8. Goldstein C. S., Bomalaski J. S., Zurier R. B., Neilson E. G., Douglas S. D. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int. 1984 Nov;26(5):733–740. doi: 10.1038/ki.1984.209. [DOI] [PubMed] [Google Scholar]
  9. Goodwin J. S., Webb D. R. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 Jan;15(1):106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  10. Guyre P. M., Morganelli P. M., Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest. 1983 Jul;72(1):393–397. doi: 10.1172/JCI110980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamburg S. I., Manejias R. E., Rabinovitch M. Macrophage activation: increased ingestion of IgG-coated erythrocytes after administration of interferon inducers to mice. J Exp Med. 1978 Feb 1;147(2):593–598. doi: 10.1084/jem.147.2.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaplan G., Weinstein D. E., Steinman R. M., Levis W. R., Elvers U., Patarroyo M. E., Cohn Z. A. An analysis of in vitro T cell responsiveness in lepromatous leprosy. J Exp Med. 1985 Sep 1;162(3):917–929. doi: 10.1084/jem.162.3.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lamperi S., Carozzi S., Icardi A., Nasini M. G. Peritoneal membrane defense mechanism in CAPD. Trans Am Soc Artif Intern Organs. 1985;31:33–37. [PubMed] [Google Scholar]
  14. Lamperi S., Carozzi S. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD). Am J Kidney Dis. 1988 Mar;11(3):225–230. doi: 10.1016/s0272-6386(88)80154-9. [DOI] [PubMed] [Google Scholar]
  15. Lamperi S., Carozzi S., Nasini M. G. Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD. ASAIO Trans. 1986 Jul-Sep;32(1):35–38. [PubMed] [Google Scholar]
  16. Peterson P. K., Lee D., Suh H. J., Devalon M., Nelson R. D., Keane W. F. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis. 1986 Feb;7(2):146–152. doi: 10.1016/s0272-6386(86)80136-6. [DOI] [PubMed] [Google Scholar]
  17. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ribi E. Beneficial modification of the endotoxin molecule. J Biol Response Mod. 1984;3(1):1–9. [PubMed] [Google Scholar]
  19. Schmidt J. A., Mizel S. B., Cohen D., Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982 May;128(5):2177–2182. [PubMed] [Google Scholar]
  20. Shaldon S., Koch K. M., Quellhorst E., Dinarello C. A. Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs. 1984;30:193–194. [PubMed] [Google Scholar]
  21. Takayama K., Qureshi N., Raetz C. R., Ribi E., Peterson J., Cantrell J. L., Pearson F. C., Wiggins J., Johnson A. G. Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infect Immun. 1984 Aug;45(2):350–355. doi: 10.1128/iai.45.2.350-355.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Takayama K., Qureshi N., Ribi E., Cantrell J. L. Separation and characterization of toxic and nontoxic forms of lipid A. Rev Infect Dis. 1984 Jul-Aug;6(4):439–443. doi: 10.1093/clinids/6.4.439. [DOI] [PubMed] [Google Scholar]
  23. Titus J. A., Haynes B. F., Thomas C. A., Fauci A. S., Segal D. M. Analysis of Fc gamma receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, T gamma cells and cells labeled with the 3Al anti-T cell monoclonal antibody. Eur J Immunol. 1982 Jun;12(6):474–479. doi: 10.1002/eji.1830120605. [DOI] [PubMed] [Google Scholar]
  24. Vogel S. N., Rosenstreich D. L. Defective Fc receptor-mediated phagocytosis in C3H/HeJ macrophages. I. Correction by lymphokine-induced stimulation. J Immunol. 1979 Dec;123(6):2842–2850. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES